TuHURA Biosciences annual net debt
2016
2017
2018
2022
2023
2024
2025
TuHURA Biosciences Net Debt Growth & History (HURA)
TuHURA Biosciences's net debt was −$3.1M for fiscal 2025.
View full TuHURA Biosciences company overviewTuHURA Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$3.1M | $9.3M | — |
| 2024 · Dec 31 | 2024-12-31 | −$12.5M | −$8.8M | — |
| 2023 · Dec 31 | 2023-12-31 | −$3.6M | $10.5M | — |
| 2022 | 2022-12-31 | −$14.1M | — | — |
| 2018 | 2018-06-30 | −$6.0M | $586,999 | — |
| 2017 | 2017-06-30 | −$6.6M | −$1.1M | — |
| 2016 | 2016-06-30 | −$5.5M | — | — |
TuHURA Biosciences quarterly net debt
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.0M | $11.4M | — |
| Q1 2026 | 2026-03-31 | −$5.8M | $214,036 | — |
| Q4 2025 | 2025-12-31 | −$3.1M | $9.3M | — |
| Q3 2025 | 2025-09-30 | −$2.6M | — | — |
| Q2 2025 | 2025-06-30 | −$8.4M | — | — |
| Q1 2025 · Mar 31 | 2025-03-31 | −$6.1M | — | — |
| Q4 2024 · Dec 31 | 2024-12-31 | −$12.5M | −$8.8M | — |
| Q4 2023 · Dec 31 | 2023-12-31 | −$3.6M | — | — |
| Q3 2019 | 2019-03-31 | −$2.2M | $6.4M | — |
| Q2 2019 | 2018-12-31 | −$3.7M | $7.3M | — |
| Q1 2019 | 2018-09-30 | −$3.9M | $9.3M | — |
| Q4 2018 | 2018-06-30 | −$6.0M | $586,999 | — |
| Q3 2018 | 2018-03-31 | −$8.5M | −$6.7M | — |
| Q2 2018 | 2017-12-31 | −$11.0M | −$7.8M | — |
| Q1 2018 | 2017-09-30 | −$13.2M | −$8.9M | — |
| Q4 2017 | 2017-06-30 | −$6.6M | −$1.1M | — |
| Q3 2017 | 2017-03-31 | −$1.9M | −$1.9M | — |
| Q2 2017 | 2016-12-31 | −$3.2M | −$2.6M | — |
| Q1 2017 | 2016-09-30 | −$4.2M | — | — |
| Q4 2016 | 2016-06-30 | −$5.5M | — | — |
| Q3 2016 | 2016-03-31 | $79,895 | — | — |
| Q2 2016 | 2015-12-31 | −$604,425 | — | — |
TuHURA Biosciences net debt trends
Between the periods ended 2016-06-30 and 2025-12-31, TuHURA Biosciences's net debt increased from −$5.5M to −$3.1M, a change of $2.3M. The latest reported quarter, Q2 2026, shows $3.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TuHURA Biosciences source filings ↗